Literature DB >> 9530954

Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa.

S Ogata1, R Koganty, M Reddish, B M Longenecker, A Chen, C Perez, S H Itzkowitz.   

Abstract

Monoclonal antibodies TKH2 and B72.3, which react with the mucin-associated sialyl-Tn(STn) antigen, preferentially bind to cancerous but not normal colonic tissues. If O-acetyl groups are removed by saponification of tissues, MAb TKH2 will react with normal colonocytes, whereas MAb B72.3 remains non-reactive. To explain this difference in binding specificity, we tested both MAbs against synthetic constructs of single (monomeric) or clustered (trimeric) STn epitopes by enzyme immunoassay. Both MAb TKH2 and MAb B72.3 reacted with trimeric STn, but MAb TKH2 demonstrated greater binding than MAb B72.3 to monomeric STn. This suggests that normal colonic mucosa expresses monomeric STn epitopes, but that with transformation to malignancy, clustered STn epitopes appear. The appearance of clustered STn epitopes during colonic carcinogenesis represents a novel pattern of carbohydrate antigen expression and implicates alterations at the level of apomucins and/or glycosyltransferases responsible for cluster epitope formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530954     DOI: 10.1023/a:1006935331756

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  37 in total

1.  Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.

Authors:  H Kobayashi; T Terao; Y Kawashima
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

2.  Purification and characterization of bovine and ovine submaxillary mucins.

Authors:  G Tettamanti; W Pigman
Journal:  Arch Biochem Biophys       Date:  1968-03-20       Impact factor: 4.013

3.  Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl-Tn antigen.

Authors:  S gata; A Chen; S H Itzkowitz
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

4.  Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.

Authors:  S Zhang; L A Walberg; S Ogata; S H Itzkowitz; R R Koganty; M Reddish; S S Gandhi; B M Longenecker; K O Lloyd; P O Livingston
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

5.  Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colon.

Authors:  C W Andrews; J M Jessup; H Goldman; D F Hayes; D W Kufe; C J O'Hara; G D Steele
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

6.  Mucin gene expression in colonic tissues and cell lines.

Authors:  S Ogata; H Uehara; A Chen; S H Itzkowitz
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

7.  Sialic acids of human large bowel mucosa: o-acylated variants in normal and malignant states.

Authors:  C M Rogers; K B Cooke; M I Filipe
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

8.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.

Authors:  T Kjeldsen; H Clausen; S Hirohashi; T Ogawa; H Iijima; S Hakomori
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

9.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

10.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

View more
  20 in total

Review 1.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  Glycosylations versus conformational preferences of cancer associated mucin core.

Authors:  J Schuman; D Qiu; R R Koganty; B M Longenecker; A P Campbell
Journal:  Glycoconj J       Date:  2000-12       Impact factor: 2.916

3.  Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.

Authors:  Vered Padler-Karavani; Nancy Hurtado-Ziola; Minya Pu; Hai Yu; Shengshu Huang; Saddam Muthana; Harshal A Chokhawala; Hongzhi Cao; Patrick Secrest; Dinorah Friedmann-Morvinski; Oded Singer; Darius Ghaderi; Inder M Verma; Yu-Tsueng Liu; Karen Messer; Xi Chen; Ajit Varki; Richard Schwab
Journal:  Cancer Res       Date:  2011-04-19       Impact factor: 12.701

Review 4.  Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.

Authors:  Inka Brockhausen
Journal:  EMBO Rep       Date:  2006-06       Impact factor: 8.807

5.  Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes.

Authors:  David J Gill; Joanne Chia; Jamie Senewiratne; Frederic Bard
Journal:  J Cell Biol       Date:  2010-05-24       Impact factor: 10.539

Review 6.  Tumour-associated carbohydrate antigens in breast cancer.

Authors:  Aurélie Cazet; Sylvain Julien; Marie Bobowski; Joy Burchell; Philippe Delannoy
Journal:  Breast Cancer Res       Date:  2010-06-08       Impact factor: 6.466

7.  Metabolic labeling of sialic acids in living animals with alkynyl sugars.

Authors:  Pamela V Chang; Xing Chen; Chris Smyrniotis; Alexander Xenakis; Tianshun Hu; Carolyn R Bertozzi; Peng Wu
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

8.  Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.

Authors:  José Alexandre Ferreira; Paula A Videira; Luís Lima; Sofia Pereira; Mariana Silva; Mylène Carrascal; Paulo F Severino; Elisabete Fernandes; Andreia Almeida; Céu Costa; Rui Vitorino; Teresina Amaro; Maria J Oliveira; Celso A Reis; Fabio Dall'Olio; Francisco Amado; Lúcio Lara Santos
Journal:  Mol Oncol       Date:  2013-03-21       Impact factor: 6.603

9.  Serum Sialyl-Tn (STN) as a Tumor Marker in Patients with Endometrial Cancer.

Authors:  Yasunori Hashiguchi; Mari Kasai; Takeshi Fukuda; Tomoyuki Ichimura; Tomoyo Yasui; Toshiyuki Sumi
Journal:  Pathol Oncol Res       Date:  2015-12-17       Impact factor: 3.201

Review 10.  Mucins as anti-cancer targets: perspectives of the glycobiologist.

Authors:  Inka Brockhausen; Jacob Melamed
Journal:  Glycoconj J       Date:  2021-03-11       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.